Get the Stockscreener App
1.82
6.67%
-0.13
Bone Biologics Corp stock is traded at $1.82, with a volume of 259.21K.
It is down -6.67% in the last 24 hours and up +33.82% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$1.95
Open:
$1.88
24h Volume:
259.21K
Relative Volume:
0.82
Market Cap:
$3.27M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.251
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
-9.00%
1M Performance:
+33.82%
6M Performance:
-67.23%
1Y Performance:
-66.30%
1-Day Range:
$1.72
$1.94
1-Week Range:
$1.72
$2.39
52-Week Range:
$1.30
$7.74
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.82 | 3.50M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
124.81 | 216.56B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.13 | 142.45B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.74 | 135.69B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.27 | 124.96B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.29 | 50.04B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bone Biologics Corp Stock (BBLG) Latest News
BBLG Stocks on the Verge: How Will They Perform? - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Bone Biologics stock rises after extending product shelf life - Investing.com
Bone-healing treatment in development now lasts 2 years on the shelf in tests - Stock Titan
Fund Flows: How iShares MSCI Emerging Markets Min stock performs in easing cycles2025 Growth vs Value & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Will Bone Biologics Corporation Equity Warrant stock benefit from AI adoptionJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда
Published on: 2025-12-20 15:31:02 - Улправда
Will Bone Biologics Corporation stock deliver shareholder valueEarnings Growth Summary & Growth Focused Stock Pick Reports - Улправда
Orthobiologics Market Landscape 2036: Strategic Benchmarking, Pricing Trends & Regional Hotspots - openPR.com
Is Bone Biologics Corporation Equity Warrant stock positioned well for digital economyEarnings Growth Summary & Smart Money Movement Tracker - DonanımHaber
How resilient is Bone Biologics Corporation Equity Warrant stock in market downturnsJuly 2025 Movers & Low Risk Growth Stock Ideas - DonanımHaber
Volume Summary: Is Bone Biologics Corporation Equity Warrant stock positioned well for digital economyMarket Growth Report & Weekly Setup with High ROI Potential - DonanımHaber
Can Bone Biologics Corporation stock withstand economic slowdownStop Loss & Reliable Intraday Trade Plans - Улправда
What insider trading reveals about Bone Biologics Corporation stock2025 Bull vs Bear & Long-Term Safe Return Strategies - Улправда
Global And China Osteoporosis Drugs Market Growth in Future - openPR.com
Trend Recap: Will CACC stock benefit from AI adoptionMarket Volume Summary & Low Drawdown Momentum Ideas - moha.gov.vn
NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review - The Manila Times
Bone Biologics (NASDAQ:BBLG) Shares Down 0.5% – Should You Sell? - Defense World
Orthobiologics Market Size to Surge USD 12.55 Billion by 2035 - Precedence Research
Bone Biologics Corp (BBLG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, from Thompson Street Capital Partners - Daytona Beach News-Journal
Why Bone Biologics Corporation Equity Warrant stock is rated strong buyQuarterly Performance Summary & Reliable Price Breakout Signals - Newser
Bone Biologics (BBLG) Stock Analysis Report | Financials & Insights - Benzinga
Biocon Biologics settles with Amgen Inc to commercialise biosimilars in Europe - Devdiscourse
Orthobiologics Market | Global Market Analysis Report2035 - Fact.MR
Book value per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
EBIT per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
Revenue per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
Net current asset value per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
Can Bone Biologics Corporation Equity Warrant stock surprise with earnings upsideWeekly Investment Report & Growth Focused Stock Reports - newser.com
Zacks Small Cap Raises Earnings Estimates for Bone Biologics - Defense World
Will Bone Biologics Corporation Equity Warrant stock attract ESG investors2025 Market Outlook & Risk Managed Investment Strategies - newser.com
Measuring Bone Biologics Corporation Equity Warrant’s beta against major indices2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
Will earnings trigger a reversal in Bone Biologics CorporationWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Bone Biologics Corporation stock attractive for growth ETFsJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
Orthobiologics Market Poised to Hit $9.39 Billion by 2029 with Accelerating Growth Trends - openPR.com
Bone Biologics Corporation Equity Warrant stock prediction for this weekMarket Performance Recap & Advanced Technical Signal Analysis - newser.com
Can KNSL stock reach $100 price target2025 Earnings Impact & Weekly High Potential Stock Alerts - newser.com
Is Bone Biologics Corporation stock supported by strong cash flows2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Will PHAXIAM Therapeutics S.A. (2E40) stock enhance shareholder valueEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Is CMTL a good long term investmentPrice Support Zones & Daily Tips From Top Market Analysts - earlytimes.in
Bone Biologics Corporation Stock Analysis and ForecastDividend Aristocrats List & Free Realize Exceptional Returns - earlytimes.in
What’s the recovery path for long term holders of Bone Biologics Corporation2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Bone Biologics Corporation stock maintain growth story2025 Price Momentum & Risk Adjusted Buy and Sell Alerts - Fundação Cultural do Pará
[10-Q] Bone Biologics Corp Quarterly Earnings Report | BBLG SEC FilingForm 10-Q - Stock Titan
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):